Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Frantisek Nehaj"'
Autor:
Winnie Chua, Victor R. Cardoso, Eduard Guasch, Moritz F. Sinner, Christoph Al-Taie, Paul Brady, Barbara Casadei, Harry J. G. M. Crijns, Elton A. M. P. Dudink, Stéphane N. Hatem, Stefan Kääb, Peter Kastner, Lluis Mont, Frantisek Nehaj, Yanish Purmah, Jasmeet S. Reyat, Ulrich Schotten, Laura C. Sommerfeld, Stef Zeemering, André Ziegler, Georgios V. Gkoutos, Paulus Kirchhof, Larissa Fabritz
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-12 (2023)
Abstract Early detection of atrial fibrillation (AF) enables initiation of anticoagulation and early rhythm control therapy to reduce stroke, cardiovascular death, and heart failure. In a cross-sectional, observational study, we aimed to identify a c
Externí odkaz:
https://doaj.org/article/d1c609a3c0d54b6f920d0755d796b56f
Autor:
Paul F. Brady, Winnie Chua, Frantisek Nehaj, Derek L. Connolly, Alya Khashaba, Yanish J. V. Purmah, Muhammad J. Ul‐Qamar, Mark R. Thomas, Chetan Varma, Renate B. Schnabel, Tanja Zeller, Larissa Fabritz, Paulus F. Kirchhof
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 4 (2022)
Background Natriuretic peptides are routinely quantified to diagnose heart failure (HF). Their concentrations are also elevated in atrial fibrillation (AF). To clarify their value in predicting future cardiovascular events, we measured natriuretic pe
Externí odkaz:
https://doaj.org/article/7e0ccd6ead5d413fade4e4dcc358f9c6
Autor:
Renata Michalova, Anna Mankova, Matej Vnucak, Stanislava Mikulova, Frantisek Nehaj, Katarina Raslova, Ivana Dedinska, Alena Jezikova, Pavel Makovicky, Peter Galajda, Marian Mokan
Publikováno v:
Biomedical Papers, Vol 163, Iss 1, Pp 90-94 (2019)
Introduction: Hormone changes during pregnancy lead to increased plasma lipid levels. When there is added disorder of lipid metabolism, this otherwise physiological change can cause extremely high triglyceride levels with potentionally life-threateni
Externí odkaz:
https://doaj.org/article/74606004967646d197eb35f29d5e7918
Autor:
Winnie Chua, Jonathan P Law, Victor R Cardoso, Yanish Purmah, Georgiana Neculau, Muhammad Jawad-Ul-Qamar, Kalisha Russell, Ashley Turner, Samantha P Tull, Frantisek Nehaj, Paul Brady, Peter Kastner, André Ziegler, Georgios V Gkoutos, Davor Pavlovic, Charles J Ferro, Paulus Kirchhof, Larissa Fabritz
Publikováno v:
PLoS Medicine, Vol 18, Iss 2, p e1003405 (2021)
BackgroundLarge-scale screening for atrial fibrillation (AF) requires reliable methods to identify at-risk populations. Using an experimental semi-quantitative biomarker assay, B-type natriuretic peptide (BNP) and fibroblast growth factor 23 (FGF23)
Externí odkaz:
https://doaj.org/article/d0513127f00845409b6b8df1ebe0041f
Autor:
Juraj Sokol MD, PhD, Frantisek Nehaj MD, Jela Ivankova RNDr, Michal Mokan MD, PhD, Jana Zolkova RNDr, Lenka Lisa MD, PhD, Ludmila Linekova MD, Marian Mokan MD, DSc, FRCP Edin, Jan Stasko MD, PhD
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 27 (2021)
A rapid and reliable assessment of the dabigatran effect is desirable in dabigatran treated patients with uncontrolled bleeding or before acute surgery. The aim of this study was to study the anticoagulant effects of dabigatran in patients with atria
Externí odkaz:
https://doaj.org/article/45ffc6ca78f2438e8496473c24f36106
Autor:
Juraj Sokol MD, PhD, Frantisek Nehaj MD, Jela Ivankova RNDr, Michal Mokan MD, PhD, Lenka Lisa MD, PhD, Jana Zolkova RNDr, Lubica Vadelova RNDr, Marian Mokan Prof, MD, DSc, FRCP Edin, Jan Stasko Prof, MD, PhD
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 26 (2020)
Edoxaban, a direct factor Xa inhibitor (FXa), is the fourth direct oral anticoagulant (DOAC) approved for clinical use. As the main adverse event is bleeding, it is relevant whether edoxaban has additional effects on platelet function. We aimed to as
Externí odkaz:
https://doaj.org/article/90ee2f85093240908bd3f4c5594d9b6e
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 25 (2019)
Multiple myeloma (MM) is a neoplastic plasma cell disorder characterized by the clonal proliferation of plasma cells in the bone marrow and presence of monoclonal protein in the blood or urine. Diverse hemostatic abnormalities have been reported in p
Externí odkaz:
https://doaj.org/article/e090f2ea849f4e87bd7ee49c3dd7c101
Publikováno v:
Journal of Thrombosis and Thrombolysis. 49:578-583
Edoxaban is an oral anticoagulant drug and a direct factor Xa inhibitor. However, it is still not fully understood if and how edoxaban impacts platelet function. This prospective study aimed to assess in vitro platelet function in patients with atria
Publikováno v:
American Journal of Therapeutics. 27:e159-e164
Background Many patients receiving dabigatran treatment might also require bisoprolol therapy. However, there is a possibility that bisoprolol as significant P-glycoprotein inhibitor might interact with dabigatran. Study question To investigate the i
Autor:
Winnie Chua, Frantisek Nehaj, Yanish Purmah, Peter Kastner, Paul Brady, André Ziegler, Larissa Fabritz, A Khashaba, Paulus Kirchhof
Publikováno v:
European Heart Journal. 42
Background/Introduction Cardiovascular (CV) diseases including atrial fibrillation and arteriosclerosis are associated with impaired cognitive function. Cognitive dysfunction can impact the process of shared clinical decision making, reduce adherence